Immunology startup raises $183M Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 22 October, 2025

Health tech is in the spotlight: from wearable tech to RWE, it's central to trends across pharma and healthcare. Join our online sessions in the AM, and in the PM, we’re live in person with a reception at NYC’s Book Club Bar. Don’t miss out — seats are limited, get your spot.

presented by The ad­vent of dig­i­tal ther­a­peu­tics and what it means for health­care

spotlight Post-Hoc: As China moves beyond ‘me-too,’ do Western regulators need to reconsider?

news Takeda makes major bispecific, ADC pact with Innovent for $1.2B upfront Ipsen to buy ImCheck for €350M to get 'superfamily' of immunotherapies Sanofi backs immunology startup, which raises $183M Series C for lead drug's pivotal trial Flagship launches Expedition Medicines to make small molecules with AI, led by former Lila Sciences and Generate exec Polaris Partners plans to raise $500M for latest biotech fund 10x Genomics sues DNA giant Illumina over patents Elevara raises $70M to test a breast cancer approach in rheumatoid arthritis

Nov 13 11:00am ET Driving down the cost: Optimising CGT with the right CDMO partner sponsored by Oxford Biomedica

Bring your rare disease drug to the Japanese market — join PMDA officials to map the path forward. Find out how — get your spot.

endpoints pharma Updated: Novo Nordisk’s chair to step down; new board to focus on ‘faster decision-making’ After financial troubles, Grail raises $325M from Hims and others Mark Cuban's online pharmacy to partner with White House's TrumpRx Regeneron's patent settlement with Celltrion paves way for another Eylea biosimilar in 2026

in case you missed it 1. CRISPR Therapeutics says its new gene editing tool is 'a significant advance' over prime editing. Prime Medicine disagrees 2. Galapagos to exit cell therapy, with loss of 365 jobs and global sites to shutter 3. GSK, Spero reveal full Phase 3 data for oral antibiotic, set for end-of-year filing 4. A chemistry startup in Scotland raises over $50M Series B to scale its ‘chemputers’ 5. News Briefing Neuphoria scraps social anxiety drug; Minerva doubles down on schizophrenia therapy 6. 'Decade of the ADCs' continues as AstraZeneca, Kelun and Merck take the stage at ESMO 7. <